Is Stoke Therapeutics Inc (NASDAQ: STOK) The Best Stock To Invest In?

Ginger Lewis

After Hours

It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility.

Stocks Info

Stoke Therapeutics Inc is listed on the NASDAQ in the Healthcare sector while operating in the Biotechnology industry. The current market capitalization of Stoke Therapeutics Inc is $1.85B. A total of 1.11 million shares were traded on the day, compared to an average of 1.20M shares.

In the most recent transaction, Allan Jonathan sold 3,978 shares of STOK for 32.28 per share on Dec 08 ’25. After the transaction, the GENERAL COUNSEL & CORP SEC now owns 11,831 company shares. In a previous transaction on Dec 08 ’25, Kaye Edward M. MD sold 13,430 shares at 32.27 per share. STOK shares that Director owns now total 49,124.

Among the insiders who bought shares, EDWARD M KAYE acquired of 13,430 shares on Dec 08 ’25 at a per-share price of $30.87. In another insider transaction, JONATHAN ALLAN bought 3,978 shares at $30.87 per share on Dec 08 ’25.

Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. In terms of 52-week highs and lows, STOK has a high of $38.69 and a low of $5.35.

As of this writing, STOK has an earnings estimate of -$0.72 per share for the current quarter. EPS was calculated based on a consensus of 8.0 estimates, with a high estimate of -$0.57 per share and a lower estimate of -$0.84. The company reported an EPS of -$0.18 in the last quarter

Balance Sheet Annually/Quarterly

As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. STOK’s latest balance sheet shows that the firm has $219.81M in Cash & Short Term Investments as of fiscal 2021. There were $1.51M in debt and $17.14M in liabilities at the time. Its Book Value Per Share was $5.59, while its Total Shareholder’s Equity was $217.78M.

Analysts Opinion

After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for STOK is Buy with a score of 4.73.

Park Telegraph
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.